MyAverix Finance
SHG · Healthcare
Tibet Rhodiola Pharmaceutical Holding Co (600211)
Drug Manufacturers - Specialty & Generic
Tibet Rhodiola Pharmaceutical Holding Co (600211) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600211
Tibet Rhodiola Pharmaceutical Holding Co (600211) — FAQ
What is 600211's P/E ratio?
The price-to-earnings (P/E) ratio for Tibet Rhodiola Pharmaceutical Holding Co (600211) is 18.00 (data as of 2026-03-24).
Does Tibet Rhodiola Pharmaceutical Holding Co pay a dividend?
Dividend yield is not available in the current snapshot for Tibet Rhodiola Pharmaceutical Holding Co (600211). Check the MyAverix Finance app for the latest dividend data.
What sector is Tibet Rhodiola Pharmaceutical Holding Co in?
Tibet Rhodiola Pharmaceutical Holding Co (600211) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600211 listed on?
600211 is listed on SHG.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.